| Year |
Citation |
Score |
| 2023 |
Corpstein CD, Hou P, Park K, Li T. Multiphysics Simulation of Local Transport and Absorption Coupled with Pharmacokinetic Modeling of Systemic Exposure of Subcutaneously Injected Drug Solution. Pharmaceutical Research. PMID 37344601 DOI: 10.1007/s11095-023-03546-5 |
0.411 |
|
| 2022 |
Haddad R, Alrabadi N, Altaani B, Li T. Paclitaxel Drug Delivery Systems: Focus on Nanocrystals' Surface Modifications. Polymers. 14. PMID 35215570 DOI: 10.3390/polym14040658 |
0.379 |
|
| 2021 |
Zheng F, Hou P, Corpstein CD, Park K, Li T. Multiscale pharmacokinetic modeling of systemic exposure of subcutaneously injected biotherapeutics. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 34324897 DOI: 10.1016/j.jconrel.2021.07.043 |
0.381 |
|
| 2019 |
Lu Y, Lv Y, Li T. Hybrid drug nanocrystals. Advanced Drug Delivery Reviews. PMID 31254558 DOI: 10.1016/j.addr.2019.06.006 |
0.318 |
|
| 2017 |
Gao W, Lee D, Meng Z, Li T. Exploring intracellular fate of drug nanocrystals with crystal-integrated and environment-sensitive fluorophores. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28844755 DOI: 10.1016/j.jconrel.2017.08.031 |
0.335 |
|
| 2017 |
Mangal S, Gao W, Li T, Zhou QT. Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities. Acta Pharmacologica Sinica. PMID 28504252 DOI: 10.1038/aps.2017.34 |
0.363 |
|
| 2016 |
Gao W, Chen Y, Thompson DH, Park K, Li T. Impact of Surfactant Treatment of Paclitaxel Nanocrystals on Biodistribution and Tumor Accumulation in Tumor-Bearing Mice. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27417039 DOI: 10.1016/J.Jconrel.2016.07.015 |
0.475 |
|
| 2015 |
Lu Y, Chen Y, Gemeinhart RA, Wu W, Li T. Developing nanocrystals for cancer treatment. Nanomedicine (London, England). 10: 2537-52. PMID 26293310 DOI: 10.2217/Nnm.15.73 |
0.598 |
|
| 2015 |
Chen Y, Li T. Cellular Uptake Mechanism of Paclitaxel Nanocrystals Determined by Confocal Imaging and Kinetic Measurement. The Aaps Journal. PMID 26104805 DOI: 10.1208/s12248-015-9774-0 |
0.306 |
|
| 2014 |
Lu Y, Wang ZH, Li T, McNally H, Park K, Sturek M. Development and evaluation of transferrin-stabilized paclitaxel nanocrystal formulation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 176: 76-85. PMID 24378441 DOI: 10.1016/J.Jconrel.2013.12.018 |
0.463 |
|
| 2014 |
Zhang H, Wang X, Dai W, Gemeinhart RA, Zhang Q, Li T. Pharmacokinetics and treatment efficacy of camptothecin nanocrystals on lung metastasis. Molecular Pharmaceutics. 11: 226-33. PMID 24294887 DOI: 10.1021/Mp4004018 |
0.577 |
|
| 2014 |
Hollis CP, Weiss HL, Evers BM, Gemeinhart RA, Li T. In vivo investigation of hybrid Paclitaxel nanocrystals with dual fluorescent probes for cancer theranostics. Pharmaceutical Research. 31: 1450-9. PMID 23619595 DOI: 10.1007/S11095-013-1048-X |
0.593 |
|
| 2013 |
Hollis CP, Weiss HL, Leggas M, Evers BM, Gemeinhart RA, Li T. Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 172: 12-21. PMID 23920039 DOI: 10.1016/J.Jconrel.2013.06.039 |
0.635 |
|
| 2011 |
Zhao R, Hollis CP, Zhang H, Sun L, Gemeinhart RA, Li T. Hybrid nanocrystals: achieving concurrent therapeutic and bioimaging functionalities toward solid tumors. Molecular Pharmaceutics. 8: 1985-91. PMID 21812439 DOI: 10.1021/Mp200154K |
0.59 |
|
| 2011 |
Zhang H, Hollis CP, Zhang Q, Li T. Preparation and antitumor study of camptothecin nanocrystals. International Journal of Pharmaceutics. 415: 293-300. PMID 21679755 DOI: 10.1016/j.ijpharm.2011.05.075 |
0.363 |
|
| Show low-probability matches. |